NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension

Por Veith, C., Kraut, S., Wilhelm, J., Sommer, N., Quanz, K., Seeger, W., Brandes, R. P., Weissmann, N., Schröder, K.
Publicado no Pulm Circ (2016)

Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels

Por Maier, T, Follmann, M, Hessler, G, Kleemann, H-W, Hachtel, S, Fuchs, B, Weissmann, N, Linz, W, Schmidt, T, Löhn, M, Schroeter, K, Wang, L, Rütten, H, Strübing, C
Publicado no Br J Pharmacol (2015)

NPY/Y(1) receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension

Por Crnkovic, S, Egemnazarov, B, Jain, P, Seay, U, Gattinger, N, Marsh, L M, Bálint, Z, Kovacs, G, Ghanim, B, Klepetko, W, Schermuly, R T, Weissmann, N, Olschewski, A, Kwapiszewska, G
Publicado em 2014